Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06292897

Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression

Integrating Tissue-based Spatial Information to Elucidate How Obesity-induced Tumour Metabolites Drive Prostate Cancer Progression

Status
Recruiting
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluate the protein expression of lactate dehydrogenase enzyme (LDHA) and MCT-1/-4 transporters, involved in lactate synthesis and transport, in prostate carcinoma tissues from severely overweight/obese (BMI \> 27.5) and non-severely overweight/normoweight (BMI \< 27.5) patients affected by prostate carcinoma. ii. Characterize the immune infiltrate in the prostate carcinoma of the aforementioned patients. iii. Assess the association between intra-tumoral lactate accumulation (using LDHA and MCT-4 protein expression levels as readouts) and alterations in the tumor immune microenvironment and/or deregulation of relevant oncogenic pathways.

Conditions

Interventions

TypeNameDescription
OTHERobservational studyobservational study

Timeline

Start date
2023-03-20
Primary completion
2026-09-15
Completion
2027-01-15
First posted
2024-03-05
Last updated
2024-03-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06292897. Inclusion in this directory is not an endorsement.